YOLFTbeta
Korean Drug Co. Ltd

Korean Drug Co. Ltd

014570 · KQ · Healthcare / Drug Manufacturers - General

2,855.00KRW+40.00 (+1.42%)

Price History

Full chart

Market Stats

Previous Close2,815.00
Open2,825.00
Day Range2,825.00 – 2,880.00
52-Week Range3,060.00 – 4,390.00
Volume3.17K
Market Cap36.00B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield5.55%
Beta0.23
50-Day Avg3,392.10
200-Day Avg3,761.40

About

Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOMr. Hai-Ryong Park
  • Employees0
  • Headquarters34, Nonhyun-ro 28, Seoul, South Korea, Korea
  • Websitehttps://www.nicepharma.com

Leadership

  • Mr. Hai-Ryong ParkChairperson, CEO & President · b. 1935
  • Sang-Hoon ParkCEO & Director · b. 1966

Financials

Income Statement

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue45.39B47.39B55.31B55.40B52.03B55.53B66.79B74.47B79.98B81.37B73.00B62.51B
Growth (%)-+4.40%+16.71%+0.17%-6.09%+6.73%+20.28%+11.49%+7.41%+1.74%-10.29%-14.37%
Cost of Revenue27.38B29.57B32.57B32.48B31.65B34.22B38.10B43.40B45.47B44.03B38.60B35.91B
Gross Profit18.01B17.82B22.74B22.92B20.38B21.31B28.69B31.07B34.52B37.35B34.40B26.60B
Gross Margin39.68%37.60%41.11%41.37%39.17%38.37%42.96%41.72%43.16%45.90%47.12%42.55%
Operating Expense15.17B15.29B16.60B18.56B16.85B17.89B18.19B19.80B20.19B19.32B25.26B19.69B
Operating Income2.84B2.53B6.13B4.36B3.53B3.42B10.50B11.27B14.33B18.03B9.14B6.91B
Operating Margin6.25%5.35%11.09%7.86%6.78%6.15%15.72%15.13%17.91%22.15%12.52%11.06%
EBITDA--------16.07B10.02B7.07B9.77B
EBITDA Margin--------20.09%12.31%9.68%15.63%
Net Income2.15B1.77B5.05B4.68B6.56B3.90B7.36B9.04B11.81B-4.92B3.00B6.51B
Net Income Margin4.74%3.74%9.13%8.45%12.61%7.01%11.02%12.14%14.76%-6.04%4.10%10.42%
Interest Expense0000003.13M1.53M2.10M3.02M4.24M3.88M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.01%

Balance Sheet

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets62.17B59.20B63.41B66.79B72.96B75.85B83.34B88.61B94.52B89.71B88.89B94.32B
Total Liabilities13.38B9.52B9.75B9.82B10.16B10.80B12.47B11.92B9.80B12.62B10.78B11.25B
Total Equity48.79B49.68B53.66B56.97B62.80B65.05B70.87B76.69B84.71B77.09B78.11B83.07B
Cash3.27B3.22B3.15B2.40B5.48B6.11B6.91B164.51M182.18M11.69B37.54M4.89B
Total Debt-----25.88M6.16M-----

Cash Flow

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow4.46B6.13B3.96B447.20M5.79B6.21B12.33B8.81B5.91B-2.00B4.87B13.11B
Investing Cash Flow-295.06M-1.83B-1.17B-114.06M-660.82M-4.18B-10.29B-8.25B-5.40B12.28B-10.89B-
Financing Cash Flow-4.16B-4.35B-2.87B-1.08B-2.05B-1.25B-1.16B-2.79B-1.91B-2.01B-1.57B-
Capital Expenditure538.19M878.05M460.84M1.13B1.30B3.05B738.47M1.15B6.09B5.93B1.04B475.05M
Free Cash Flow------11.57B7.65B-564.37M-2.64B3.83B12.63B
Dividends Paid656.82M766.29M764.89M1.09B982.20M1.09B1.09B1.63B1.83B1.94B1.62B1.73B
FCF to OCF------93.84%86.84%-9.55%131.95%78.59%96.38%
Dividend Paid to FCF------9.42%21.37%-324.82%-73.61%42.29%13.69%

Earnings

Report DateDec 31, 2010Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------------------------------------------------
EPS Actual84.5253.85128.0790.2467.7527.5417.6523.7740.5112.3210.890.7445.8933.8457.5859.0556.5726.7976.592.3248.0292.4091.84230.3842.27100.13111.90174.8546.1727.4099.12428.84109.92-24.94-61.20333.7854.85333.35126.18161.19229.44150.36138.72315.81268.91187.46345.68293.01347.54-480.90170.49-492.99310.57-103.11249.43-178.7475.41183.92176.39167.51111.00-317.82
Surprise--------------------------------------------------------------
Timing--------------------------------------------------------------

Key Statistics & Ratios

Market Cap36.00B
Enterprise Value-1.73B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.55
Price / Book0.44
Revenue (TTM)65.39B
Gross Profit (TTM)28.80B
EBITDA9.68B
Profit Margin2.27%
Operating Margin15.12%
Return on Equity1.88%
Return on Assets5.09%
Shares Outstanding10.83M
Shares Float5.35M
Beta0.23
Dividend Yield5.55%
Dividend Rate180.00
Payout Ratio131.31%

Dividends

20251×
180.00Dec 29, 2025
20241×
160.00Dec 27, 2024
20231×
150.00Dec 27, 2023
20221×
180.00Dec 28, 2022
20211×
170.00Dec 29, 2021
20201×
150.00Dec 29, 2020
20191×
100.00Dec 27, 2019
20181×
100.00Dec 27, 2018
20171×
90.00Dec 27, 2017
20161×
100.00Dec 28, 2016
20151×
70.00Dec 29, 2015
20141×
70.00Dec 29, 2014
20131×
60.00Dec 27, 2013
20121×
70.00Dec 27, 2012
20111×
70.00Dec 28, 2011
20101×
70.00Dec 29, 2010
20091×
60.00Dec 29, 2009
20081×
60.00Dec 29, 2008
20071×
60.00Dec 27, 2007
20061×
50.00Dec 27, 2006
20051×
50.00Dec 28, 2005
20041×
40.00Dec 29, 2004
20031×
40.00Dec 29, 2003
20021×
40.00Dec 27, 2002

Stock Splits

  • Apr 17, 200610:1